Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$7.02 - $9.76 $120,217 - $167,140
17,125 New
17,125 $154,000
Q3 2022

Nov 14, 2022

BUY
$5.33 - $11.3 $29,549 - $62,647
5,544 Added 47.87%
17,125 $119,000
Q2 2022

Aug 15, 2022

SELL
$4.66 - $13.96 $332,369 - $995,683
-71,324 Reduced 86.03%
11,581 $64,000
Q1 2022

May 11, 2022

BUY
$11.89 - $24.68 $1,581 - $3,282
133 Added 0.16%
82,905 $1.07 Million
Q4 2021

Feb 11, 2022

SELL
$24.14 - $35.18 $22,088 - $32,189
-915 Reduced 1.09%
82,772 $2.06 Million
Q3 2021

Nov 12, 2021

BUY
$27.38 - $42.21 $264,408 - $407,621
9,657 Added 13.04%
83,687 $2.76 Million
Q2 2021

Aug 11, 2021

SELL
$26.34 - $46.62 $802,895 - $1.42 Million
-30,482 Reduced 29.17%
74,030 $2.14 Million
Q1 2021

May 13, 2021

SELL
$45.96 - $68.02 $164,950 - $244,123
-3,589 Reduced 3.32%
104,512 $5.29 Million
Q4 2020

Feb 09, 2021

BUY
$13.72 - $51.57 $335,824 - $1.26 Million
24,477 Added 29.27%
108,101 $5.25 Million
Q3 2020

Nov 12, 2020

SELL
$10.54 - $18.47 $3,646 - $6,390
-346 Reduced 0.41%
83,624 $1.48 Million
Q2 2020

Aug 12, 2020

BUY
$10.37 - $20.64 $207,866 - $413,728
20,045 Added 31.36%
83,970 $1.53 Million
Q1 2020

May 06, 2020

BUY
$9.63 - $17.14 $60,842 - $108,290
6,318 Added 10.97%
63,925 $774,000
Q4 2019

Feb 14, 2020

BUY
$7.2 - $13.2 $15,141 - $27,759
2,103 Added 3.79%
57,607 $759,000
Q3 2019

Nov 07, 2019

BUY
$8.95 - $15.72 $74,669 - $131,151
8,343 Added 17.69%
55,504 $496,000
Q2 2019

Aug 12, 2019

BUY
$14.61 - $22.45 $124,389 - $191,139
8,514 Added 22.03%
47,161 $748,000
Q1 2019

May 14, 2019

BUY
$14.24 - $22.28 $294,041 - $460,059
20,649 Added 114.73%
38,647 $727,000
Q4 2018

Feb 11, 2019

BUY
$17.86 - $28.77 $77,958 - $125,581
4,365 Added 32.02%
17,998 $413,000
Q3 2018

Nov 09, 2018

BUY
$13.39 - $26.25 $182,545 - $357,866
13,633 New
13,633 $0

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.